Chapter 10: Fetal Development and Genetics

Fetal development progresses through three sequential phases beginning at fertilization and extending through birth, with each stage marked by distinct cellular and physiological transformations. The preembryonic period encompasses the earliest cell divisions and implantation, the embryonic period involves the formation of primary germ layers and rudimentary organ structures, and the fetal period is characterized by growth, maturation, and functional refinement of developing systems. Supporting this progression are critical anatomical structures including the placenta, which mediates maternal-fetal nutrient and gas exchange, the umbilical cord serving as the vascular connection between fetus and placenta, and amniotic fluid providing protection and an optimal growth environment. Unique circulatory pathways including the ductus venosus, ductus arteriosus, and foramen ovale allow fetal blood to bypass nonfunctional lungs and liver during intrauterine life, redirecting oxygenated blood from the placenta directly to systemic circulation. The genetic basis of development is established through deoxyribonucleic acid organized into chromosomal structures, which determine an individual's genotype and corresponding observable physical characteristics. Inheritance patterns follow predictable mechanisms categorized as autosomal dominant, autosomal recessive, X-linked, or multifactorial, with each pattern reflecting distinct probabilities of trait transmission across generations. Developmental disruptions arise from exposure to environmental agents called teratogens during sensitive embryonic windows, or from genetic anomalies including point mutations, chromosomal number variations such as trisomy conditions, and structural chromosomal rearrangements. Clinically, healthcare providers employ pedigree analysis to map familial disease patterns, implement genetic screening protocols to detect abnormalities prenatally or before conception, and provide genetic counseling to inform reproductive planning and risk assessment in families with known hereditary conditions.